Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Chaudhuri
K Ray
KR
Dhawan
Vandena
V
Basu
Sumit
S
Jackson
Gordon
G
Odin
Per
P
D001021:Aortic Valve / Q000473:pathology*; D001971:Bromocriptine / Q000009:adverse effects*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000009:adverse effects*; D004873:Ergolines / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects*
D018491:Dopamine Agonists; D004873:Ergolines; D010479:Pergolide; D001971:Bromocriptine; D000077465:Cabergoline